Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Fl 1
New Haven, CT 06519Phone+1 203-785-2815Fax+1 203-737-7618
Summary
- I am a board certified urologist with clinical and research focus on prostate and kidney cancer. To date, I have performed over 2200 robotic prostatectomies and 200 laparoscopic/robotic nephrectomies. My clinical and research interest is in high-risk and metastatic prostate cancer with the focus on the role of surgery. In addition, I am investigating treatment resistance mechanism in prostate cancer and have jointly developed candidate molecules that target the androgen signaling pathway. My research activity has resulted in more than 190 publications and funding support from the Department of Defense and various philanthropic organizations.
Education & Training
The Wharton School of the University of PennsylvaniaMBA, Management, 2015 - 2017
University of California (Irvine)Fellowship, Minimally Invasive Urologic Surgery, 2003 - 2005
Baylor College of MedicineResidency, Urology, 1999 - 2003
National Cancer InstitutePost-Doctoral Fellowship, 2000 - 2001- Baylor College of MedicineInternship, Transitional Year, 1997 - 1998
Northwestern University The Feinberg School of MedicineClass of 1997
Northwestern UniversityPhD, Tumor Cell Biology, 1993 - 1996- Northwestern University Graduate SchoolPhD, Integrated Graduate Program in Tumor Cell Biology, 1993 - 1996
- University of California, BerkeleyB.A., Biochemistry, With High Honors, 1986 - 1990
Certifications & Licensure
CA State Medical License 2003 - Present
FL State Medical License 2021 - Present
CT State Medical License 2021 - 2025
NJ State Medical License 2005 - 2025- American Board of Urology Urology
Awards, Honors, & Recognition
- Award of Hope The Cancer Institute of New Jersey Foundation, 2010
- Edwin Beer Research Fellowship New York Academy of Medicine, 2006
- Outstanding Laparoendoscopic Resident Surgeon The Society of Laparoendoscopic Surgeons, 2003
- Join now to see all
Clinical Trials
- Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate Start of enrollment: 2008 Dec 12
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
- Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery Start of enrollment: 2017 Jun 20
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsFactors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalizat...Joshua Sterling, Zorimar Rivera-Núñez, Hiren V. Patel, Nicholas J. Farber, Sinae Kim
Clinical Genitourinary Cancer. 2020-03-20 - 7 citationsLongitudinal recovery patterns of penile length and the underexplored benefit of long-term phosphodiesterase-5 inhibitor use after radical prostatectomy.Young Suk Kwon, Nicholas J. Farber, Jiwoong Yu, Kevin Rhee, Christopher Han
BMC Urology. 2018-05-09 - 109 citationsDiagnosis of bladder cancer and prediction of survival by urinary metabolomics.Xing Jin, Seok Joong Yun, Pildu Jeong, Isaac Yi Kim, Wun-Jae Kim
Oncotarget. 2014-02-12
Journal Articles
- Trends and Outcomes of Lymphadenectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-Weighted Analysis of the National Cancer DatabaseParth K Modi, Tina M Mayer, Isaac Y Kim, Sammy E Elsamra, Thomas L Jang, Eric A Singer, Urologic Oncology
- Cytoreductive Prostatectomy: Evidence in Support of a New Surgical ParadigmIzak Faiena, Eric A. Singer, Chris Pumill, and Isaac Y. Kim, Int J Oncology, 1/1/2014
- Factors related to patient-perceived satisfaction after robot-assisted radical prostatectomy based on the expanded prostate cancer index composite surveyJeong Hyun Kim, Yun-Sok Ha, Seong Jin Jeong, Wun-Jae Kim, Thomas L. Jang, and Isaac Yi Kim, Prostate Cancer and Prostatic Disease, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Prostate cancer bone metastases acquire resistanct to androgen deprivation via WNT5A medicated BMP-6 inductionIsaac Yi Kim, Urological Research Society Annual Meeting, Munich, Germany, 1/18/2014
- Active Surveillance for Prostate Cancer: Rethinking Prostate-Specific Antigen Density Eligibility CriteriaYunsok Ha, Neal Patel, Amirali Salmasi, Eric Singer, Jihyeong Yu, Jeong Hyun Kim, Wun-Jae Kim, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
- Off-target Effect of Sildenafil is Neuroprotective via Phosphodiesterase Type-4Amirali Salmasi, Neal Patel, Geun Taek Lee, Isaac Yi Kim, 109th annual meeting of the American Urological Association, Orlando, FL, 1/16/2014
- Join now to see all
Lectures
- Indications for adjuvant radiation following RARP at Rutgers-CINJSeoul, Korea - 1/7/2015
- Prostate cancer bone metastases acquire resistance to androgen deprivation via Wnt5a mediate BMP6 inductionVancouver, Canada - 1/19/2014
- Wnt5A/BMP-6 Loop and Castration Resistance in Prostate Cancer Bone MetastasesDallas, TX - 1/16/2014
- Join now to see all
Other
- Robot-Assisted Laparoscopic Radical ProstatectomyIsaac Y. Kim
1/20/2010 - Laparoscopy 1Isaac Y. Kim, 26th World Congress Endourology and SWL
Shanghai, China - 1/30/2008 - Expression and Regulation of Transforming Growth Factor-B Receptors in Normal and Malignant Prostatic Epithelial CellsIsaac Y. Kim, University Microfilm Inc Dissertation Services
1/1/1996
Press Mentions
Defining the Landscape of Prostate Cancer TreatmentJune 28th, 2022- Rutgers Cancer Institute of New Jersey Experts Address Prostate Cancer in Wake of Recent Announcement from Television Personality Al RokerNovember 6th, 2020
Similar Incidence of DNA Damage Response Pathway Alterations Between Localized and Metastatic Prostate CancerMay 3rd, 2019- Join now to see all
Professional Memberships
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
